Xavier Gonzalez
Overview
Explore the profile of Xavier Gonzalez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
360
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pernas S, Sanfeliu E, Villacampa G, Salvador J, Perello A, Gonzalez X, et al.
NPJ Breast Cancer
. 2024 Nov;
10(1):101.
PMID: 39592624
With the incorporation of cyclin-dependent kinase inhibitors in early breast cancer (BC), a better identification of biomarkers is needed. The PROMETEO II trial aimed to evaluate the antitumor activity of...
2.
Friedmann D, Gonzalez X, Moses A, Watts T, Degleris A, Ticea N, et al.
bioRxiv
. 2024 Oct;
PMID: 39416005
Serotonin neurons from the raphe nuclei project across the entire brain and modulate diverse physiology and behavior by acting on over a dozen receptors. Here, we took a step towards...
3.
Colino-Lage H, Guerrero-Gomez D, Gomez-Orte E, Gonzalez X, Martina J, Dansen T, et al.
Free Radic Biol Med
. 2024 Jul;
223:369-383.
PMID: 39059513
Basic Helix-Loop-Helix (bHLH) transcription factors TFEB/TFE3 and HLH-30 are key regulators of autophagy induction and lysosomal biogenesis in mammals and C. elegans, respectively. While much is known about the regulation...
4.
Kingsley S, Seo Y, Wood A, Wani K, Gonzalez X, Irazoqui J, et al.
Sci Rep
. 2024 Jun;
14(1):13177.
PMID: 38849503
Overconsumption of dietary sugar can lead to many negative health effects including the development of Type 2 diabetes, metabolic syndrome, cardiovascular disease, and neurodegenerative disorders. Recently, the human intestinal microbiota,...
5.
Gonzalez X, Irazoqui J
Mol Microbiol
. 2024 Apr;
122(3):387-402.
PMID: 38623070
Microbiotas are complex microbial communities that colonize specific niches in the host and provide essential organismal functions that are important in health and disease. Understanding the ability of each distinct...
6.
Distinct members of the CeMbio reference microbiota exert cryptic virulence and infection protection
Gonzalez X, Irazoqui J
bioRxiv
. 2023 Nov;
PMID: 37961109
Microbiotas are complex microbial communities that colonize specific niches in the host and provide essential organismal functions that are important in health and disease. A key aspect is the ability...
7.
Goswamy D, Gonzalez X, Labed S, Irazoqui J
Front Immunol
. 2023 Mar;
14:1094145.
PMID: 36860863
In recent years, transcription factors of the Microphthalmia-TFE (MiT) family, including TFEB and TFE3 in mammals and HLH-30 in , have emerged as important regulators of innate immunity and inflammation...
8.
Lopez Gonzalez A, Del Barco Berron S, Grau I, Galan M, Fernandez B, Cortes A, et al.
Cancers (Basel)
. 2022 Dec;
14(23).
PMID: 36497361
Background: Luminal advanced breast cancer (ABC) patients eventually progress on endocrine therapy. REVERT aimed to explore whether eribulin could restore endocrine sensitivity in a randomized, non-comparative phase II trial. Methods:...
9.
Prat A, Paz-Ares L, Juan M, Felip E, Garralda E, Gonzalez B, et al.
Future Oncol
. 2022 Oct;
PMID: 36200668
Improved selection of cancer patients who are most likely to respond to immune checkpoint inhibitors remains an unmet clinical need. Recently, a positive correlation between levels of mRNA and clinical...
10.
Cejalvo J, Falato C, Villanueva L, Tolosa P, Gonzalez X, Pascal M, et al.
Cancer Treat Rev
. 2022 Apr;
106:102392.
PMID: 35436729
Immunotherapy has revolutionized the oncology field during the last years, mainly with the introduction of immune checkpoint inhibitors in the clinical routine. Despite the recent approval of these drugs for...